Better therapeutics through microarrays
- 1 December 2002
- journal article
- review article
- Published by Springer Nature in Nature Genetics
- Vol. 32 (S4) , 547-552
- https://doi.org/10.1038/ng1042
Abstract
DNA microarrays are an integral part of the process for therapeutic discovery, optimization and clinical validation. At an early stage, investigators use arrays to prioritize a few genes as potential therapeutic targets on the basis of various criteria. Subsequently, gene expression analysis assists in drug discovery and toxicology by eliminating poor compounds and optimizing the selection of promising leads. Integral to this process is the use of sophisticated statistics, mathematics and bioinformatics to define statistically valid observations and to deduce complex patterns of phenotypes and biological pathways. In short, microarrays are redefining the drug discovery process by providing greater knowledge at each step and by illuminating the complex workings of biological systems.Keywords
This publication has 37 references indexed in Scilit:
- Medical applications of microarray technologies: a regulatory science perspectiveNature Genetics, 2002
- RNA interferenceNature, 2002
- Empirical bayes methods and false discovery rates for microarraysGenetic Epidemiology, 2002
- Prediction of central nervous system embryonal tumour outcome based on gene expressionNature, 2002
- Computational analysis of microarray dataNature Reviews Genetics, 2001
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences, 2001
- Testing for Differentially-Expressed Genes by Maximum-Likelihood Analysis of Microarray DataJournal of Computational Biology, 2000
- Functional Discovery via a Compendium of Expression ProfilesCell, 2000
- A gene expression database for the molecular pharmacology of cancerNature Genetics, 2000
- It's the genes! EST access to human genome contentBioEssays, 1996